Moran Zhang

871-900 (out of 1200)

Moran Zhang is a finance and economics reporter at The International Business Times. Her work has appeared in the Wall Street Journal Digital Network’s MarketWatch, United Press International and the San Diego Union Tribune. She is a graduate of the Medill School of Journalism at Northwestern University and holds a master’s degree in business journalism. She is based in New York. Moran can be reached at m.zhang@ibtimes.com, and she can be followed on Twitter at @moranzhang.

Moran Zhang

Hologic To Buy Gen-Probe For $3.7B, Gen-Probe Shares Soar

Medical device maker Hologic Inc. said Monday it would acquire diagnostic test maker Gen-Probe Inc. for about $3.7 billion in cash to expand its molecular diagnostic business, international presence and cross-selling opportunities.

US 1Q GDP Grew 2.2%, Less Than Expected

The U.S. economy expanded at a slower-than-expected pace in the first quarter, reflecting a deceleration in inventories and nonresidential fixed investment that was partly offset by the biggest gain in consumer spending in more than a year.

Caterpillar Inc. (CAT) Q1 Profit Rises, Lifts Forecast

Caterpillar Inc. (NYSE: CAT), the largest maker of construction and mining equipment, reported a 29 percent jump in its first-quarter profit that topped analysts' estimates and boosted its full-year outlook, as U.S. builders replaced their aging machinery and demand for mining equipment boomed.

Home Prices Hit New Lows in Feb: S&P/Case-Shiller

The American market for single-family homes fell to new lows in February, but prices declined at a slower rate compared to the previous month, a private report showed Tuesday, as the housing market continues to struggle.

FOMC Preview: Policy To Stay Put At April Meeting

Federal Reserve officials are expected to be in wait-and-see mode on extra stimulus at the April Federal Open Market Committee meeting this week, as little has changed since the March meeting to warrant policy changes, economists say.

All Eyes On April FOMC, US 1Q GDP: Next Week’s Economic Events

The Federal Open Market Committee meeting on April 24-25, Fed Chairman Ben S. Bernanke's comments during the post-meeting press conference, and an advance reading on U.S. gross domestic product in the first quarter will dominate the economic calendar next week.

50 Key Earnings Reports To Watch, April 23-27

Earnings season is in full swing, and about 80 percent of the companies that have already reported topped estimates. We ran a screen and produced a list of 50 key companies set to report their earnings between April 23 and 27.

Ford Plans $760 Million Factory in China

Ford Motor Co. (NYSE: F) said Thursday it will build a $760 million assembly plant in Hangzhou as part of a plan to double its production capacity in China by 2015 and catch up with global rivals.

March US Leading Economic Index Up 0.3%, Tops Expectations

The index of U.S. leading economic indicators rose 0.3 percent in March, extending its upward trend for a sixth month. Thursday's data points to a more positive outlook despite subdued consumer expectations and weakness in manufacturing new orders.

European Banks May Be Forced To Sell $3.8 Trillion In Assets: IMF

European banks could be forced to shrink their balance sheets by as much as $3.8 trillion through 2013, or almost 7 percent of total assets, with a quarter of the deleveraging likely to come from cuts in lending and the remainder from sales of securities and noncore assets, the International Monetary Fund said Wednesday.

Roche Walks Away From $6.8B Illumina Takeover Bid

Swiss drugmaker Roche Holding AG (ROG.VX) said Wednesday that it decided not to extend beyond Friday a $6.8 billion hostile offer for gene sequencing specialist Illumina Inc. (Nasdaq: ILMN) after forecasting that the incumbents directors of Illumina will be re-elected.

SXC Health, Catalyst Health To Merge In $4.4 Billion Deal

SXC Health Solutions Corp. (Nasdaq: SXCI) agreed on Wednesday to buy fellow pharmacy benefit manager Catalyst Health Solutions Inc. (Nasdaq: CHSI) for about $4.4 billion in cash and stock, to expand its presence in the business of paying and processing prescription drug claims.

March US Housing Starts Fall, Permits Surge

U.S. home construction fell 5.8 percent in March even with the help of warmer-than-normal weather in the month, but new building permits jumped to the highest level since September 2008.

Pages